Clinical and Research Approaches to Treat Non-union Fracture
- 310 Downloads
Purpose of Review
Impaired healing outcomes or even non-unions after bone injury are still a highly relevant problem in the daily clinical life. Especially within an aging population, the occurrence of bone fractures increases and thus novel treatment approaches to overcome compromised bone regeneration are needed.
The gold standard to treat delayed or non-healing bone injuries is still the use of autologous bone grafts to foster regeneration. Besides its successful treatment outcome, it also has disadvantages: a second surgery is needed in order to harvest the bone material and the material is highly limited. Looking into the recent literature, a multitude of different research approaches were already conducted to identify new possible strategies to treat impaired bone regeneration: application of mesenchymal stromal cells, platelet lysates, growth factors, interference in the immune system, or bone formation stimulation by ultrasound.
This review gives an overview of the treatment approaches actually performed in the clinic as well as at the bench in the context of compromised bone healing. It clearly highlights the complexity of the nature of non-healing bone fractures as well as patient-dependent factors influencing the healing process.
KeywordsBone fracture healing Non-union Compromised healing Autologous bone graft Cell therapy Immune therapy
Funding was provided by the DFG FOR2165 and the Berlin-Brandenburg School for Regenerative Therapies.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as:• of importance•• of major importance
- 9.•• Schmidt-Bleek K, Schell H, Lienau J, Schulz N, Hoff P, Pfaff M, et al. Initial immune reaction and angiogenesis in bone healing. J Tissue Eng Regen Med. 2014;8(2):120–30. This study provided the proof of the strong interdependency of the switch to the anti-inflammatory phase and the starting revascularization, which is a prerequisite for a successful healing outcome, in the early fracture healing phase. CrossRefPubMedGoogle Scholar
- 14.• van Basten BM, Houben IB, Blokhuis TJ. The non-union scoring system: an interobserver reliability study. Eur J Trauma Emerg Surg. 2017; This study evaluated and confirmed the reliability of the NUSS score (introduced by Calori and colleagues) to determine the severity category of a fracture and the definitive treatment Google Scholar
- 28.Claes L, Blakytny R, Gockelmann M, Schoen M, Ignatius A, Willie B. Early dynamization by reduced fixation stiffness does not improve fracture healing in a rat femoral osteotomy model. J Orthop Res. 2009;27(1):22–7.Google Scholar
- 30.Schmidt-Bleek K, Kwee BJ, Mooney DJ, Duda GN. Boon and bane of inflammation in bone tissue regeneration and its link with angiogenesis. Tissue Eng Part B Rev. 2015;Google Scholar
- 35.Ratko TA, Belinson SE, Samson DJ, Bonnell C, Ziegler KM, Aronson N. Bone morphogenetic protein: the state of the evidence of on-label and off-label use. Rockville (MD): AHRQ Technology Assessments; 2010.Google Scholar
- 38.Cierny G 3rd, Byrd HS, Jones RE. Primary versus delayed soft tissue coverage for severe open tibial fractures. A comparison of results. Clin Orthop Relat Res. 1983;178:54–63.Google Scholar
- 53.Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am Vol. 2005;87(7):1430–7.Google Scholar
- 56.Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am Vol. 2002;84-A(12):2123–34.CrossRefGoogle Scholar
- 58.Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am Vol. 2001;83-A(Suppl 1(Pt 2)):S151–8.Google Scholar
- 73.Kusuyama J, Bandow K, Shamoto M, Kakimoto K, Ohnishi T, Matsuguchi T. Low intensity pulsed ultrasound (LIPUS) influences the multilineage differentiation of mesenchymal stem and progenitor cell lines through ROCK-cot/Tpl2-MEK-ERK signaling pathway. J Biol Chem. 2014;289(15):10330–44.CrossRefPubMedPubMedCentralGoogle Scholar
- 81.•• Reinke S, Geissler S, Taylor WR, Schmidt-Bleek K, Juelke K, Schwachmeyer V, et al. Terminally differentiated CD8(+) T cells negatively affect bone regeneration in humans. Sci Transl Med. 2013;5(177):177ra36. This study was the first to clearly show the high interconnectivity of the amount of potential unfavorable CD8+ terminally differentiated effector memory T cells (TEMRA), and thus of the adaptive immunity, and of impaired bone regeneration in fracture patients. CrossRefPubMedGoogle Scholar
- 82.Schlundt C, El Khassawna T, Serra A, Dienelt A, Wendler S, Schell H, et al. Macrophages in bone fracture healing: Their essential role in endochondral ossification. Bone. 2015.Google Scholar
- 84.Pobloth, A., Checa, S., Razi, H., Petersen, A., Weaver, J. C., Schmidt-Bleek, K., Windolf, M., Tatai, A. Á., Roth, C. P., Schaser, K. D., Duda, G. N., Schwabe, P. Mechano-biologically optimized 3D titanium-mesh scaffolds enhance regeneration in large segmental bone defects. Cience Transl Med, 2018, in press.Google Scholar